Industry’s CER Efforts Should Follow PCORI Methods, Cmte. Member Yancy Says

Pharma companies’ comparative effectiveness research should be “in sync” with nationalized approach that the Patient-Centered Outcomes Research Institute will bring, Clyde Yancy, member of the new institute’s Methodology Committee, suggests.

More from Clinical Trials

More from R&D